A further mechanism of CD19-negative immune escape, particularly relevant in MLL-rearranged B-ALL, is lineage switch from lymphoid to myeloid leukemia, with consequent loss of expression of B-lymphoid lineage antigens (93, 94). Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.